Charles River Laboratories International Inc.
CRL
Market Cap$12.69B
Close$
$300.00
30.4% upsideCharles River Laboratories International Target Price Details
Target Price by Analysts
30.4% upsideCharles River Laboratories International Target Price Details$152.95
33.5% downside
Current Fair Value
33.5% downsideOvervalued by 33.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.69 Billion |
|---|---|
| Enterprise Value | $15.06 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $9.22 |
| Beta | 1.43 |
| Outstanding Shares | 51,510,790 |
| Avg 30 Day Volume | 461,269 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 26.74 |
|---|---|
| PEG | -15374.46 |
| Price to Sales | 2.88 |
| Price to Book Ratio | 3.33 |
| Enterprise Value to Revenue | 3.65 |
| Enterprise Value to EBIT | 24.4 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
ESG Score
No data
About Charles River Laboratories International Inc.
17,000 employees
CEO: James Foster Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our...